Breathing in science to eliminate TB

In support of World TB Day, 24 March, the Forum of International Respiratory Societies (FIRS), of which GOLD is a founding member, calls on the tuberculosis (TB) community to challenge ourselves to think differently, champion science and embrace evidence-based innovation if we are to end TB.

We have made great strides towards eliminating TB over the last 100 years.

The progress made to date has only been possible because of our commitment to research and innovation. While it is important to reflect on our achievements, we must continue to advance our knowledge through research and implement it into policy and practice. For the elimination of TB, this means:

• Prioritising active identification and treatment of everyone with TB to prevent transmission of the infectious disease.
• Using of the latest technological advances at our disposal – digital communications, imaging, and diagnostic tools.
• Undertaking clinical, public health and operational research to create knowledge for action.
• Involving communities and motivating them to embrace the concept of eliminating TB.
• Challenging TB inequity globally – we can no longer accept that people in low- and middle-income countries are, every day, infected, becoming sick and dying with TB, while people in high-income countries are unaware that TB still exists.

With deaths increasing for the first time in over a decade – 1.5 million deaths in 2020 – TB must be treated as an emergency. Which is why we call on world leaders to keep the promises they made at the UN High-Level Meeting 2018 and #InvestToEndTB.

Despite the limited funding (in particular when compare with COVID-19), there have been significant TB research triumphs in the past decade, such as:

• Molecular tests make diagnosis possible in less than two hours, rather than 2–4 weeks
• Treatment of multidrug-resistant TB has been shortened from two years of toxic, injectable agents to six months of an all-oral regimen
• Treatment of TB infection has been cut from nine months to as short as 1–3 months with safer and better tolerated regimens

These breakthroughs are testament to our commitment to science. In order to make the next great breakthrough in TB elimination we must nurture an environment where evidence-based innovation can flourish. It will be challenging to sustain such an environment given the current hardships we are facing globally, including the millions of refugees fleeing the war in Ukraine.

These times of unrest provide good conditions for TB and other lung diseases to run rampant. We must, however, remain positive and challenge ourselves to think differently, champion science and embrace evidence-based innovation to end TB.

The Forum of International Respiratory Societies’ statement of support for Ukraine following the Russian invasion

The Forum of International Respiratory Societies (FIRS) stands in solidarity with the people of Ukraine as the unfolding humanitarian disaster created by Russia’s invasion continues. We are deeply concerned about the impact on the health and wellbeing of communities in Ukraine and pledge our strong support to frontline workers, affected members, partner organisations, and the 1,7 million people who have had to flee their homes.
The displacement of thousands of people and the barrage of shelling that damages sanitation and health infrastructures create a humanitarian crisis with devastating health consequences, including exacerbating respiratory diseases that have already escalated due to COVID-19.
Ukrainian doctors and nurses have to postpone other care to focus on treating the wounded, despite the desperate shortages of essential hospital supplies, medicines and healthcare staff. WHO has warned that dangerously low oxygen reserves make it difficult to treat severe respiratory illnesses such as pneumonia and growing numbers of patients with COVID-19.
Compounding the risk to patients, critical hospital services are also jeopardized by power shortages, and ambulances transporting patients are in danger of getting caught in the crossfire. Thousands of lives are at risk.
As we witness the escalation of atrocities, we call on our members and the wider respiratory community to support humanitarian aid initiatives for the Ukrainian people wherever possible.
Our FIRS partner, the European Respiratory Society, has collated a list of initiatives giving support to refugees, providing medical aid packages, supporting paramedics and doctors on the front line, and offering emergency responses to children.
Please consider supporting one or more of these active humanitarian aid initiatives:
• International Committee of the Red Cross
• Ukraine Humanitarian Fund – United Nations
• UNICEF – Emergency support to conflict in eastern Ukraine
• UNHCR – The UN Refugee Agency
• Médecins Sans Frontières (MSF)
• International Medical Corps
• Polish Medical Mission
Links to external sources of medical advice can be found in the ERS disaster medicine resource.
Alongside this call for support, the European Respiratory Society is currently taking steps to suspend collaborations with Russian and Belarusian societies.
The Forum of International Respiratory Societies (FIRS) is an organisation comprised of the world’s leading international respiratory societies working together to improve lung health globally. The goal of FIRS is to unify and enhance efforts to improve lung health through the combined work of its more than 70,000 members globally.

FIRS comprises the American College of Chest Physicians (CHEST), American Thoracic Society (ATS), the Asian Pacific Society of Respirology (APSR), Asociación Latino Americana De Tórax (ALAT), European Respiratory Society (ERS), International Union Against Tuberculosis and Lung Diseases (The Union), Pan African Thoracic Society (PATS), the Global Initiative for Asthma (GINA), and the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

World’s Respiratory Societies Support Community Action and Education for Lung Cancer Awareness Day

Cape Town, Glenview, Lausanne, Montevideo, New York, Paris, and Tokyo

August 1, 2021 – In support of World Lung Cancer Day on August 1, the Forum of International Respiratory Societies (FIRS), of which GOLD is a founding member, stresses the importance of community action and early screening to prevent and treat lung cancer

Responsible for 25% of all cancer deaths, lung cancer remains a topic for concern. According to the World Health Organization, each year, more people die of lung cancer than of colon, breast, and liver cancers combined. Worldwide, in 2020, there were 2.21 million new cases of lung cancer and 1.80 million deaths. Despite these alarming statistics, the rate of lung cancer is dropping because of tobacco cessation efforts.

World Lung Cancer Day is an excellent opportunity to raise awareness for people affected by lung cancer and also effective ways for its prevention, the most important being tobacco cessation. Eliminating tobacco use is the number one way to reduce lung cancer cases. Community can play an important role through education around preventable risk factors for lung cancer and the importance of early detection to most effectively treat lung cancer.

To reduce the prevalence of lung cancer, the Centers for Disease Control and Prevention recommends community action and education including:

• Public education around lung cancer risk factors
• Reducing minors’ access to tobacco products and e-cigarettes
• Helping people quit using tobacco products
• Helping people avoid secondhand smoke
• Reducing exposure to radon
• Encouraging people to be screened for lung cancer as recommended

In addition to tobacco cessation, access to screening and early detection is vital for reducing lung cancer deaths through early detection and treatment. If lung cancer is found at an early stage, when it is small and before it has spread, it is more likely to be successfully treated.
Lung cancer screening with a low-dose tomography (also known as low-dose CT or LDCT) scan is recommended for at risk people to detect the earliest stages of lung cancer before symptoms occur. The American Cancer Society recommends that all current or former smokers and those over the age of 55 consider seeking a low-dose CT scan screening to potentially detect lung cancer in its earliest stages.

When they present, lung cancer symptoms include change in mucus, chest or back pain, coughing up blood and difficulty swallowing. Timely and equitable access to health care for assessment and treatment is vital.

About the Forum of International Respiratory Societies (FIRS): The Forum of International Respiratory Societies (FIRS) is an organisation comprised of the world’s leading international respiratory societies working together to improve lung health globally: American College of Chest Physicians (CHEST), American Thoracic Society (ATS), Asian Pacific Society of Respirology (APSR), Asociación Latino Americana De Tórax (ALAT), European Respiratory Society (ERS), International Union Against Tuberculosis and Lung Diseases (The Union), Pan African Thoracic Society (PATS), Global Initiative for Asthma (GINA), and the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

The goal of FIRS is to unify and enhance efforts to improve lung health through the combined work of its more than 70,000 members globally. For more information about FIRS, please contact Lisa Roscoe lisa.roscoe@firsnet.org.

Global respiratory groups join WHO, calling on world leaders to act on the commitments made to end TB.

In support of World TB Day, 24 March, the Forum of International Respiratory Societies (FIRS), of which GOLD is a founding member, joins the World Health Organisation (WHO) campaign urging governments to act on the commitments made to end TB.

TB remains one of the world’s deadliest infectious killers. According to the WHO each day, nearly 4000 lose their lives to TB and close to 28,000 people fall ill with this preventable and curable disease, this equates to 1.5 million deaths and 10 million people falling ill to TB each year.

Despite significant progress against TB in recent years, 3 million people with TB disease are still undiagnosed. 1 in 3 people with TB do not access quality care for reasons ranging from gaps in research and development and insufficient or underfunded health services, to long and difficult treatments or because of stigma. In addition, a quarter of the world’s population is estimated to be living with TB infection, the bacteria that causes the disease. People with TB infection are estimated to have a 5-10 percent chance of developing the disease over their lifetime but TB preventive therapy reduces a person’s risk of developing active TB by 60 to 90 percent.

To achieve the Sustainable Development Goals targets and the United Nations High-Level Meeting commitments by 2030 and 2022 respectively, governments must accelerate their investments and actions to ensure access to quality TB prevention and care.

FIRS calls for urgent action to advance TB prevention through rapid scale up of access to preventive treatment for TB infection for those most at risk of falling ill of TB including:

• Four million children under five years of age
• 20 million other household contacts of people affected by TB
• Six million people living with HIV and AIDS.

“Time is running out. Globally, we are falling short of the target to provide at least 30 million people with TB preventive treatment by 2022.” said Mark Cohen, President of FIRS. “We are at a critical time, as we continue to battle the COVID-19 pandemic, we cannot put End TB progress at risk.”

The COVID-19 pandemic has made the world aware of how deadly respiratory viruses can be. We have seen how public health and political will can be mobilised quickly and it’s time for us to treat TB as the emergency that it is.

Find out more about the WHO 2021 World TB Day campaign.

Congratulations to Kevin Mortimer and other GOLD contributors on today’s print release of the new Lancet article discussing lung health in low-income and middle-income countries. We hope this helps to further the important discussion of meaningful solutions to improve chronic respiratory diseases, as well as health equity to reduce morbidity and mortality worldwide.

Click here for a free download of this article!

The Forum of International Respiratory Societies (FIRS), an organisation comprised of the world’s leading international respiratory societies, calls for urgent access to affordable COVID-19 vaccines globally.

The COVID-19 pandemic has affected more than 72 million people worldwide and resulted in more than 1.6 million deaths to date. No country has been spared, and throughout the world this pandemic has placed a huge burden on health systems and on economies. Many countries are now experiencing a second wave of infections, which are more severe than the first initial wave. The elderly and those with underlying vulnerabilities including diabetes, chronic lung or heart disease, hypertension, obesity or immunosuppression are at higher risk for developing severe disease.

Incredibly, less than a year after the start of the pandemic, effective, safe vaccines are now being approved for emergency use and some countries have already started vaccinating their citizens. The rapid development and authorisation of these vaccines must be accompanied by close monitoring for further guidance and optimal use. However, roll out of vaccines is currently predominantly in high-income countries. There is an urgent need for affordable vaccines to be made available in low- and middle-income countries, especially as there may be limited access to health care and to life saving supportive therapy including oxygen in these settings.

“Now is a critical time in the fight against COVID-19. We need to ensure affordable, equitable access, transparency and fair distribution of approved vaccines to protect people in all countries.” said Stephanie Levine, MD President of FIRS. “This pandemic has affected people around the world and we now need a global effort to ensure that all countries can access preventive, diagnostic and therapeutic measures to beat it.”

FIRS is comprised of: American College of Chest Physicians (CHEST), American Thoracic Society (ATS), Asian Pacific Society of Respirology (APSR), Asociación Latino Americana De Tórax (ALAT), European Respiratory Society (ERS), International Union Against Tuberculosis and Lung Diseases (The Union), Pan African Thoracic Society (PATS), Global Initiative for Asthma (GINA), and the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

The goal of FIRS is to unify and enhance efforts to improve lung health globally through the combined work of its more than 100,000 members.

For more information about FIRS please visit firsnet.org or contact Lisa Roscoe lisa.roscoe@firsnet.org.

To Meet HIV World Health Goals, TB Treatment Must be Maintained During COVID-19 Response

1 December 2020— The global COVID-19 pandemic has strained health care systems around the world. In the developing world, tuberculosis (TB), which shares several symptoms with COVID-19, is often the first sign that a person has HIV. This World AIDS Day, the Forum of International Respiratory Societies (FIRS), of which GOLD is a founding member, is calling on governments, health advocates and non-government organisations to strengthen their response to AIDS and tuberculosis, and to ensure that TB services are maintained throughout their response to COVID-19.

TB is the leading cause of death among those with HIV/AIDS worldwide, accounting for about one in three deaths, according to the 2020 UNAIDS Global Update. Yet, 60 percent of people living with HIV and tuberculosis are unaware of their co-infection and therefore not receiving the care that could prevent serious illness and death, according to the World Health Organisation (WHO).

“Patients who are HIV positive remain at high risk for TB, and as the world directs its attention to addressing the COVID-19 pandemic, it is it critical that TB programs continue to detect and treat cases,” said Juan C. Celedón, MD, DrPH, ATSF, President of American Thoracic Society, a FIRS founding member. “When treated with preventative therapy, latent TB can be managed, reducing the chance of death from AIDS and TB by about 40 percent.”

Shortly after AIDS emerged, it fuelled a global resurgence of TB that continues in many low- and middle-income countries. According to the Centers for Disease Control and Prevention, HIV infection is the strongest risk factor for progressing from latent to active TB.

COVID-19 presents another challenge, as the symptoms are similar to TB and patients can become ill with both diseases. According to the WHO, experience with COVID-19 infection in TB patients remains limited but people ill with both TB and COVID-19 may have poorer treatment outcomes, especially if TB treatment is interrupted. HIV also increases the risk of other infectious respiratory diseases, including Pneumocystis jiroveci pneumonia and bacterial pneumonia, both of which can be life threatening.

Since the AIDS epidemic began, the WHO estimates that 75.7 million people have become infected with HIV and 32.7 million people have died from AIDS-related illnesses.

Education, prevention strategies and new medicines, particularly antiretroviral therapies, have reduced the number of AIDS deaths by 60 percent per year since their global peak in 2004.

Still, UNAIDS estimates that in 2019, 38 million people were living with AIDS and about 1.7 million people became newly infected.

FIRS believes a global response to HIV/AIDS can be strengthened by:

• Increasing awareness of the continuing global threat of HIV-related disease and its link to TB and other respiratory diseases.
• Improving the health outcomes of people living with HIV through patient care and research into improved treatments and treatment strategies for both HIV and TB.
• Reducing the incidence and severity of HIV-related disease by strengthening mother-to-child transmission prevention programs and increasing the early use of antiretroviral therapy.
• Improving HIV education in at-risk communities to reduce the incidence of new HIV infections.
• Reducing HIV-related health disparities and inequities.

“As the global medical community responds to COVID-19, it must also continue to strengthen its response to HIV/AIDS, as well as TB prevention and treatment,” said Dr. Celedón. “Not long ago, HIV/AIDS and TB seemed insurmountable, yet HIV/AIDS is now a manageable chronic illness thanks to antiretroviral therapies, and TB is preventable and curable if treated appropriately. As a result, the WHO has set a goal of ending the AIDS epidemic by 2030. The progress we have made against HIV/AIDS and TB should serve as an inspiration for medical systems dealing with COVID-19, as proof that epidemics can be managed.”

About the Forum of International Respiratory Societies (FIRS)

The Forum of International Respiratory Societies (FIRS) is an organisation comprised of the world’s leading international respiratory societies working together to improve lung health globally: American College of Chest Physicians (CHEST), American Thoracic Society (ATS), Asian Pacific Society of Respirology (APSR), Asociación Latino Americana De Tórax (ALAT), European Respiratory Society (ERS), International Union Against Tuberculosis and Lung Diseases (The Union), Pan African Thoracic Society (PATS), Global Initiative for Asthma (GINA), and the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

The goal of FIRS is to unify and enhance efforts to improve lung health through the combined work of its more than 70,000 members globally.

For more information about FIRS please contact Lisa Roscoe lisa.roscoe@firsnet.org

On World Pneumonia Day, 12 November, the Forum of International Respiratory Societies (FIRS), of which GOLD is a founding member, calls for urgent progress to end the preventable burden of pneumonia and deaths.

Pneumonia is the single biggest infectious killer of adults and children – claiming the lives of 2.5 million, including 672,000 children, in 2019. Children under five years old and adults over 70 years make up 75 percent of pneumonia deaths. Most pneumonia deaths occur in low and middle-income countries. The coronavirus (COVID-19) pandemic has highlighted the danger of pneumonia particularly in adults, with almost 47 million cases globally and 1.2 million deaths to date.

To help increase the visibility of pneumonia and to raise public awareness of its risks, FIRS has joined the World Pneumonia Awareness Campaign, Pneumolight. More than 216 iconic landmarks in 47 countries across the globe will light up blue to mark World Pneumonia Day. The event will shine a blue spotlight on this neglected yet leading killer of children.

Landmarks which will turn blue include: the King George Square in Brisbane, Australia; the Macau Tower in China; the Leaning Tower of Pisa in Italy; Niagara Falls in Canada; the Cibeles Fountain in Madrid; the National Library of Belarus; Milad – the highest tower in Iran; Olympic Tower in Munich, Germany; the Torch Doha in Qtar; the CN Tower in Toronto, Canada – the highest tower in North America and Table Mountain in South Africa.

FIRS President, Dr. Stephanie Levine, FIRS member the Pan African Thoracic Society President, Prof Joseph Aluoch, and past-President Prof Heather Zar will speak at the Global Conference for World Pneumonia Day, joining a diverse panel of more than 21 speakers from different organisations committed to fighting pneumonia.

To end the preventable burden of childhood pneumonia and deaths there is a need to:

• Raise awareness about pneumonia, the leading killer of young children.
• Strengthen, accelerate and sustain interventions to prevent and treat pneumonia.
• Focus on equitable access to, and delivery of comprehensive pneumonia prevention and control programs.
• Design specific strategies to reach the “harder-to reach” populations to improve their accessibility to available interventions.
• Conduct research to develop innovative strategies to reduce the burden of pneumonia.

Together, we can end preventable deaths from pneumonia.

FIRS calls upon governments, health care providers, researchers, funders and families to ensure:

• Improved, equitable and sustained access to effective pneumonia prevention and control interventions for all by all.
• Strengthened health systems that promptly and effectively deliver strategies to reduce pneumonia deaths including provision of effective antibiotics and oxygen delivery systems.
• Increased support for strategies to prevent pneumonia including immunisation, prevention of mother-to-child HIV transmission, provision of anti-retroviral therapy for HIV-infected children, reduction of exposure to tobacco and air pollution, and increasing access to safe drinking water and sanitation.
• Support for research towards innovative diagnostic, prevention and treatment strategies.

If we do not take decisive action now, 11 million more children will die by 2030.

About the World Pneumonia Awareness Campaign, Pneumolight

To find out more about the World Pneumonia Awareness Campaign, Pneumolight, contact Catia Cillóniz on catiacilloniz@yahoo.com.

Join the Global Conference for World Pneumonia Day on November 12th, 2020, beginning at 16:00 CET and concluding at 20:00 CET by visiting the Pneumolight YouTube Channel.

About the Forum of International Respiratory Societies (FIRS)

The Forum of International Respiratory Societies (FIRS) is an organisation comprised of the world’s leading international respiratory societies working together to improve lung health globally: American College of Chest Physicians (CHEST), American Thoracic Society (ATS), Asian Pacific Society of Respirology (APSR), Asociación Latino Americana De Tórax (ALAT), European Respiratory Society (ERS), International Union Against Tuberculosis and Lung Diseases (The Union), Pan African Thoracic Society (PATS), Global Initiative for Asthma (GINA), and the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

The goal of FIRS is to unify and enhance efforts to improve lung health through the combined work of its more than 70,000 members globally.

For more information about FIRS please contact Lisa Roscoe lisa.roscoe@firsnet.org.

WorldPneumoniaDayGraphic1

WorldPneumoniaDayGraphic2

WorldPneumoniaDayGraphic3

WorldPneumoniaDayGraphic4

WorldPneumoniaDayGraphic5

World Lung Day 2020: Respiratory groups call for research to prevent, detect and treat respiratory infections

Cape Town, Glenview, Lausanne, Montevideo, New York, Paris, Tokyo, 25 September 2020

Today, on World Lung Day (WLD), GOLD is united with members of the Forum of International Respiratory Societies (FIRS) and WLD partner organisations to advocate for respiratory health globally and call for more research to prevent, detect and treat respiratory infections.

In 2020, the coronavirus (COVID-19) pandemic has made the world aware of how deadly respiratory viruses can be. In reality, respiratory infections have been with us for a very long time and will continue to be a major source of human suffering and death.

Apart from viruses, there are many other sources of respiratory infection that cause much human disease. These include bacteria, fungi and other organisms which may infect the upper airways (nose, sinuses and throat) and/or, more worryingly, the lower airways and lungs (such as bronchitis and or pneumonia).

They can cause lung symptoms such as cough, fast breathing, green sputum and breathlessness, as well as general symptoms such as fever, feeling ill and weight loss. Chest pain while breathing or coughing may also occur.

Respiratory infections impose an immense worldwide health burden:

• Each year almost 700,000 children die from pneumonia. 80 percent of deaths are in children under 2 years and adults above 65 years. Almost all deaths occur in low and middle-income countries.
• Each year there are 10 million new cases of tuberculosis (TB) and 1.5 million deaths. Deaths from TB occur mostly in children under 5 years and adults in the 20-35 year age range. Over 95 percent of TB deaths occur in low- and middle-income countries.
• Viral respiratory infections can occur in epidemics and spread rapidly within communities across the globe, to become global pandemics. COVID-19 is one such viral respiratory infection that has affected more than 25 million people worldwide and nearly 860,000 have died by the beginning of September 2020. The burden will continue to exponentially increase in the near future.

WLD is an annual lung health awareness day, occurring yearly on 25 September. To date nearly 200 organisations and many more individuals support WLD through lung heath advocacy and action. This year, with respiratory health firmly in the spotlight, it is a great opportunity to raise awareness of the burden of respiratory infections and call for:

• Health security and prevention of future COVID-19 outbreaks.
• Predictive tests to show who is immune and who will develop disease from novel infections.
• Diagnostic tests to identify and treat those at risk to progress once infected.
• High quality randomised controlled trials to find the best vaccines and treatments.
• Access to effective, affordable vaccines and treatments for all.
• Educating all on the benefits and safety of the Influenza and Pneumococcal vaccines, as well as the COVID-19 vaccine once developed.

To learn more about World Lung Day and download the fact sheet, graphics and pledge campaign go to the World Lung Day Toolkit.

About the Forum of International Respiratory Societies (FIRS)

The Forum of International Respiratory Societies (FIRS) is an organisation comprised of the world’s leading international respiratory societies working together to improve lung health globally: American College of Chest Physicians (CHEST), American Thoracic Society (ATS), Asian Pacific Society of Respirology (APSR), Asociación Latino Americana De Tórax (ALAT), European Respiratory Society (ERS), International Union Against Tuberculosis and Lung Diseases (The Union), Pan African Thoracic Society (PATS), Global Initiative for Asthma (GINA), and the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

The goal of FIRS is to unify and enhance efforts to improve lung health through the combined work of its more than 70,000 members globally.

image

image1

image2

image3

image4

image5

image6

image7

image8

image9

image10

image11

Respiratory groups stress lung cancer risks and importance of early screening and treatment

Cape Town, Glenview, Lausanne, Montevideo, New York, Paris, Tokyo, 1 August 2020

In support of World Lung Cancer Day, the Forum of International Respiratory Societies (FIRS), of which GOLD is a founding member, calls for more awareness and understanding of lung cancer risk factors, as well as the importance of early screening and treatment.

Lung cancer is responsible for nearly 1 in 5 cancer deaths according to the World Health Organization. While lung cancer and breast cancer are diagnosed at the same rate (11.6 percent), lung cancer kills more people yearly than breast, colon and prostate cancers combined. Lung cancer mortality is projected to reach 2.45 million by 2030, a 39 percent increase in just over a decade.

While most understand that smoking is the single greatest risk factor for lung cancer at 80 percent of all cases, other lesser known risk factors include the environment and genetics. Environmental exposure to radon, asbestos, arsenic, beryllium and uranium has been linked to lung cancer. The risk of lung cancer also increases with a history of cancer in another part of the body, age, family history, radiation to the chest area and lung diseases like chronic obstructive pulmonary disease (COPD).

Access to screening options and education is vital for early detection and treatment. Low-income countries, where survival rates are significantly below the average, report only a 15 percent availability of treatment through public health systems. More that 90 percent of high-income countries report vital access to care.

Lung cancer symptoms include change in mucus, chest or back pain, coughing up blood and difficulty swallowing. Tests that may be used to diagnose lung cancer include chest x-rays, CT and PET scans, bronchoscopy and needle biopsies. If you are a current or former smoker and over the age of 55, you may be a candidate for a low-dose CT scan screening that can potentially detect lung cancer in its earliest stages.

About FIRS: The Forum of International Respiratory Societies (FIRS) is an organisation comprised of the world’s leading international respiratory societies working together to improve lung health globally: American College of Chest Physicians (CHEST), American Thoracic Society (ATS), Asian Pacific Society of Respirology (APSR), Asociación Latino Americana De Tórax (ALAT), European Respiratory Society (ERS), International Union Against Tuberculosis and Lung Diseases (The Union), Pan African Thoracic Society (PATS), Global Initiative for Asthma(GINA), and the Global Initiative for Chronic Obstructive Lung Disease (GOLD).

The goal of FIRS is to unify and enhance efforts to improve lung health through the combined work of its more than 70,000 members globally.

Click here to read this year’s Lung Cancer Fact Sheet: World Lung Cancer Day 2020 Fact Sheet

LUNG CANCER DAY 2020 FIRS

LUNG CANCER DAY 2020 FIRS2

LUNG CANCER DAY 2020 FIRS3

LUNG CANCER DAY 2020 FIRS4

LUNG CANCER DAY 2020 FIRS5